Long-term follow-up of limertinib (ASK120067) in patients with locally advanced or metastatic EGFR T790M NSCLC: A multicentre, single-arm, phase IIb study
机构:[1]Hunan Canc Hosp, Thorac Med Oncol Dept, Changsha, Peoples R China[2]Capital Med Univ, Beijing Chest Hosp, Oncol Dept, Beijing, Peoples R China[3]Zhejiang Canc Hosp, Canc Res Inst, Med Oncol Dept, Hangzhou, Peoples R China浙江省肿瘤医院[4]Fuzhou Pulomnary Hosp Fujian, Oncol, Fuzhou, Peoples R China[5]TMUCIH Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China[6]Beijing Canc Hosp, Beijing, Peoples R China[7]Harbin Med Univ, Affiliated Hosp 3, Resp Med, Harbin, Peoples R China[8]China Med Univ, Hosp 1, Shenyang, Peoples R China[9]Fujian Canc Hosp, Fuzhou, Peoples R China[10]Fujian Med Univ, Canc Hosp, Fuzhou, Peoples R China[11]Xinxiang Med Univ, Affiliated Hosp 1, Xinxiang, Peoples R China[12]Changzhou Fourth Peoples Hosp, Changzhou, Peoples R China[13]Yunnan Canc Hosp, Internal Med Dept, Yunnan Canc Ctr, Kunming, Peoples R China[14]Kunming Med Univ, Affiliated Hosp 3, Kunming, Peoples R China[15]Yunnan Canc Ctr, Kunming, Peoples R China[16]Gen Med Hanzhong 3201 Hosp, Hanzhong, Peoples R China[17]Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China[18]USTC, Affiliated Hosp 1, Anhui Prov Hosp, Oncol Dept, Hefei, Peoples R China[19]Zhejiang Univ, Affiliated Hosp 1, Hangzhou, Peoples R China浙江大学医学院附属第一医院[20]Air Force Med Univ, Affiliated Hosp 2, Tangdu Hosp, Xian, Peoples R China[21]Jilin Univ, China Japan Union Hosp, Hosp 3, Jilin, Peoples R China吉林大学中日联谊医院[22]Hebei Med Univ, Hosp 4, North Gate, Shijiazhuang, Hebei, Peoples R China河北医科大学第四医院[23]Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Med Oncol Dept, Canc Hosp, Beijing, Peoples R China
第一作者机构:[1]Hunan Canc Hosp, Thorac Med Oncol Dept, Changsha, Peoples R China
推荐引用方式(GB/T 7714):
Wu L.,Li B.,Fan Y.,et al.Long-term follow-up of limertinib (ASK120067) in patients with locally advanced or metastatic EGFR T790M NSCLC: A multicentre, single-arm, phase IIb study[J].JOURNAL OF THORACIC ONCOLOGY.2025,20(3):
APA:
Wu, L.,Li, B.,Fan, Y.,Shi, Q.,Li, K....&Shi, Y-K..(2025).Long-term follow-up of limertinib (ASK120067) in patients with locally advanced or metastatic EGFR T790M NSCLC: A multicentre, single-arm, phase IIb study.JOURNAL OF THORACIC ONCOLOGY,20,(3)
MLA:
Wu, L.,et al."Long-term follow-up of limertinib (ASK120067) in patients with locally advanced or metastatic EGFR T790M NSCLC: A multicentre, single-arm, phase IIb study".JOURNAL OF THORACIC ONCOLOGY 20..3(2025)